Abstract
The purpose of this study was to evaluate the diagnostic sensitivity and specificity of a commercial C6 enzyme immuno assay, QuickC6, in acute Lyme neuroborreliosis (LNB) in endemic areas. Paired sera and cerebral spinal fluids (CSFs) from 60 patients with definite LNB, eight patients with possible LNB, 18 patients with conditions mimicking LNB and 42 persons with noninfectious neurological disease were examined. The case definition of LNB was based on strict criteria during a prospective 4-month follow-up. The sensitivity of QuickC6 was 98% both in sera and CSFs, and the diagnostic specificity was 61% in sera and 88% in CSFs. QuickC6 is a sensitive, simple and cost-effective screening test in serum and CSF in diagnosis of acute LNB. Specificity needs further evaluation.
Abbreviations
- Bb antibodies:
-
antibodies to Borrelia burgdorferi
- CSF:
-
cerebrospinal fluid
- EIA:
-
enzyme immuno assay
- ITBb :
-
intrathecal production of borrelia antibodies
- LNB:
-
Lyme neuroborreliosis
- TBE:
-
tick-borne encephalitis
References
Stanek G, O’Connell S, Cimmino M, Aberer E, Kristoferitsch W, Granstrom M, Guy E, Gray J (1996) European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis. Wien Klein Wochenschr 13:741–747
Wilske B (2003) Diagnosis of Lyme Borreliosis in Europe. Vector Borne Zoonotic Dis 3:215–27
Hansen K, Lebech AM (1991) Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi-specific immunoglobulin G, A, and M. Ann Neurol 30:197–205
Ljostad U, Mygland A, Skarpaas T (2003) [Neuroborreliosis in Vest-Agder]. Tidsskr Nor Laegeforen 6:610–613
Liang FT, Steere AC, Marques AR, Johnson BJ, Miller JN, Philipp MT (1999) Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi VlsE. J Clin Microbiol 37:3990–3996
Panelius J, Lahdenne P, Saxen H, Carlsson SA, Heikkila T, Peltomaa M, Lauhio A, Seppala I (2003) Diagnosis of Lyme neuroborreliosis with antibodies to recombinant proteins DbpA, BBK32, and OspC, and VlsE IR6 peptide. J Neurol 250:1318–1327
Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP (2005) Diagnosis of Lyme borreliosis. Clin Microbiol Rev 18:484–509
Bacon RM, Biggerstaff BJ, Schriefer ME, Gilmore RD, Jr, Philipp MT, Steere AC, Wormser GP, Marques AR, Johnson BJ (2003) Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J Infect Dis 15:1187–1199
Magnarelli LA, Lawrenz M, Norris SJ, Fikrig E (2002) Comparative reactivity of human sera to recombinant VlsE and other Borrelia burgdorferi antigens in class-specific enzyme-linked immunosorbent assays for Lyme borreliosis. J Med Microbiol 51:649–655
Marques AR, Martin DS, Philipp MT (2002) Evaluation of the C6 peptide enzyme-linked immunosorbent assay for individuals vaccinated with the recombinanat OspA Vaccine. J Clin Microbiol 40:2591–2593
Acknowledgement
The Research Department, Sørlandet Hospital, Kristiansand and Helse Sør RHF, supported the work. We thank Randi Eikeland, Rune Midgard, Jan Schepel, Tormod Helås, Åse Berg and Odd Sættem for recruiting patients to the study and Pèter A. Csángó and Svein Gunnar Gundersen for carefully reviewing the manuscript. The Regional Committee for Medical Research Ethics in Southern Norway gave ethical recommendation. The work was performed in compliance with current Norwegian laws.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Skarpaas, T., Ljøstad, U., Søbye, M. et al. Sensitivity and specificity of a commercial C6 peptide enzyme immuno assay in diagnosis of acute Lyme neuroborreliosis. Eur J Clin Microbiol Infect Dis 26, 675–677 (2007). https://doi.org/10.1007/s10096-007-0336-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-007-0336-y